59 related articles for article (PubMed ID: 25868301)
21. General aspects of diabetes mellitus.
Alam U; Asghar O; Azmi S; Malik RA
Handb Clin Neurol; 2014; 126():211-22. PubMed ID: 25410224
[TBL] [Abstract][Full Text] [Related]
22. [Glucocorticoid-induced hyperglycemia - mechanisms, detection and therapeutic management].
Siegmund T
MMW Fortschr Med; 2014 Nov; 156 Spec no 2():90-2. PubMed ID: 25552026
[No Abstract] [Full Text] [Related]
23. The Current Drug Treatment Landscape for Diabetes and Perspectives for the Future.
Bailey CJ
Clin Pharmacol Ther; 2015 Aug; 98(2):170-84. PubMed ID: 25963904
[TBL] [Abstract][Full Text] [Related]
24. Practical management of diabetes in critically ill patients.
Boord JB; Graber AL; Christman JW; Powers AC
Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 1):1763-7. PubMed ID: 11734423
[No Abstract] [Full Text] [Related]
25. Safety of antidiabetes medications: An update.
Bailey CJ
Clin Pharmacol Ther; 2015 Aug; 98(2):185-95. PubMed ID: 25820533
[TBL] [Abstract][Full Text] [Related]
26. [Early-morning hyperglycemia in patients with diabetes mellitus types 1 and 2].
Jasik M
Wiad Lek; 1989 Apr; 42(8):529-32. PubMed ID: 2697976
[TBL] [Abstract][Full Text] [Related]
27. [The current aspects of the pharmacological correction of hyperglycemia in patients with non-insulin-dependent diabetes mellitus (type 2)].
Gorbenko NI
Eksp Klin Farmakol; 1999; 62(5):71-8. PubMed ID: 10572759
[TBL] [Abstract][Full Text] [Related]
28. The pharmacological treatment of hyperglycemia in NIDDM. American Diabetes Association.
Diabetes Care; 1995 Nov; 18(11):1510-8. PubMed ID: 8722084
[No Abstract] [Full Text] [Related]
29. Insulin degludec--the impact of a new basal insulin on care in type 2 diabetes.
Khunti K; Cos X; Rutten G
Prim Care Diabetes; 2014 Jul; 8(2):119-25. PubMed ID: 24207030
[TBL] [Abstract][Full Text] [Related]
30. Diabetes mellitus in adults.
Saltman RJ; Orland MJ; Levin ME
Compr Ther; 1988 Sep; 14(9):55-64. PubMed ID: 3064962
[No Abstract] [Full Text] [Related]
31. Effect of blood glucose concentrations on the development of chronic complications of diabetes mellitus.
Swidan SZ; Montgomery PA
Pharmacotherapy; 1998; 18(5):961-72. PubMed ID: 9758308
[TBL] [Abstract][Full Text] [Related]
32. How to manage hypoglycaemia.
Hill J
Nurs Times; 2011 Oct 11-17; 107(40):20, 22-3. PubMed ID: 22132490
[TBL] [Abstract][Full Text] [Related]
33. [Oral antidiabetic drugs--1. For each patient the proper drug].
Bachmann W
MMW Fortschr Med; 2000 Mar; 142(9):41-4. PubMed ID: 10795481
[No Abstract] [Full Text] [Related]
34. [Type 1 diabetes mellitus: pathogenesis, symptoms and therapy].
Gero L
Orv Hetil; 2010 Mar; 151(13):533-9. PubMed ID: 20304746
[TBL] [Abstract][Full Text] [Related]
35. Treatment options for paediatric diabetes.
Verrotti A; Chiuri RM; Blasetti A; Mohn A; Chiarelli F
Expert Opin Pharmacother; 2010 Oct; 11(15):2483-95. PubMed ID: 20666700
[TBL] [Abstract][Full Text] [Related]
36. Pharmacologic treatment of type 2 diabetes mellitus: realities and perspectives.
Abdallah MP; Hirbli K
J Med Liban; 1999; 47(4):233-7. PubMed ID: 10641451
[No Abstract] [Full Text] [Related]
37. Defining the role of incretin mimetic therapy in the management of type 2 diabetes.
Unger J; Nadeau DA
J Fam Pract; 2007 Dec; 56(12 Suppl New):S4-S10. PubMed ID: 18664341
[TBL] [Abstract][Full Text] [Related]
38. Type of diabetes mellitus: Does it matter to the clinician?
Hoogwerf BJ
Cleve Clin J Med; 2020 Feb; 87(2):100-108. PubMed ID: 32015063
[TBL] [Abstract][Full Text] [Related]
39. Emerging Targets for Therapeutic Development in Diabetes and Its Complications: The RAGE Signaling Pathway.
Litwinoff E; Hurtado Del Pozo C; Ramasamy R; Schmidt AM
Clin Pharmacol Ther; 2015 Aug; 98(2):135-44. PubMed ID: 25974754
[TBL] [Abstract][Full Text] [Related]
40. Glycemic variability: adverse clinical outcomes and how to improve it?
Zhou Z; Sun B; Huang S; Zhu C; Bian M
Cardiovasc Diabetol; 2020 Jul; 19(1):102. PubMed ID: 32622354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
